[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

First-Time Generics - December 2006

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 OXANDROLONE TABLETS USP, 2.5 MG UPSHER-SMITH LABORATORIES, INC. OXANDRIN TABLETS 12/1/2006
2 OXANDROLONE TABLETS USP, 2.5 MG 10 MG SANDOZ INC. OXANDRIN TABLETS 12/1/2006
3 PAROXETINE HYDROCHLORIDE ORAL SUSPENSION, 10 MG/5 ML APOTEX INC. PAXIL ORAL SUSPENSION 12/4/2006
4 TRANDOLAPRIL TABLETS, 1 MG, 2 MG, AND 4 MG TEVA PHARMACEUTICALS USA MAVIK TABLETS 12/12/2006
5 BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP, 150 MG AND 300 MG (ONCE-A-DAY) ANCHEN PHARMACEUTICALS, INC. WELLBUTRIN XL EXTENDED RELEASE TABLETS 12/14/2006
6 ALBUTEROL SULFATE & IPRATROPIUM BROMIDE INHALATION SOLUTION, 3 MG (0.083%) AND 0.5 MG (0.017%); 3 ML VIALS SANDOZ INC. DUONEB INHALATION SOLUTION 12/21/2006
7 ONDANSETRON ORAL SOLUTION USP, 4 MG/5 ML ROXANE LABORATORIES, INC. ZOFRAN ORAL SOLUTION 12/26/2006
8 ONDANSETRON ORALLY DISINTEGRATING TABLETS USP, 16 MG AND 24 MG KALI LABORATORIES, INC. ZOFRAN ODT 12/26/2006
9 ONDANSETRON HYDROCHLORIDE TABLETS, 16 MG (BASE) DR. REDDY'S LABORATORIES LIMITED ZOFRAN TABLETS 12/26/2006
10 ONDANSETRON HYDROCHLORIDE TABLETS, 4 MG (BASE), 8 MG (BASE), AND 24 MG (BASE) DR. REDDY'S LABORATORIES LIMITED ZOFRAN TABLETS 12/26/2006
11 ONDANSETRON ORALLY DISINTEGRATING TABLETS USP, 4 MG AND 8 MG KALI LABORATORIES, INC. ZOFRAN ODT 12/26/2006
12 METHSCOPOLAMINE BROMIDE TABLETS USP, 2.5 MG AND 5 MG BOCA PHARMACAL, INC. PAMINE TABLETS & PAMINE FORTE TABLETS 12/28/2006

Back to Top      Back to Approvals

Date created: January 4, 2007

horizonal rule